May 12, 2025
Artificial Intelligence (AI) has already been used in many areas of clinical development and clinical...
Apr 06, 2025
Small biotech companies encounter significant challenges in designing and implementing clinical development programmes. These companies...
Mar 24, 2025
Accelerating Innovation in Structural Heart Care: Bioforum’s Role in Pi-Cardia’s FDA Journey Bioforum is proud...
Feb 17, 2025
Sample size is a quantity of immense strategic and ethical importance in treatment development. It...
Jan 16, 2025
Introduction With over 50%[1] of drugs in development reflecting rare/orphan and oncology indications alone, the...
Jan 12, 2025
Drug development is a high-stakes, high-cost endeavor. Every new drug entering clinical trials requires careful...
Dec 10, 2024
Value of strategic statistical consultants Many sponsors are restricting the utilization of strategic statistical consultants...
May 19, 2024
Data standards support the robust organization, analysis, and reporting of clinical trials and many regulatory...
Apr 19, 2024
If you’re contemplating a Functional Service Provision (FSP) model to enhance your biometric team, understanding...
Apr 19, 2024
Choosing to supplement your internal biometrics team via Functional Service Provision (FSP) offers numerous benefits,...
Apr 19, 2024
Pharma and biotech companies often face the challenge of needing additional biometrics support, whether due...
Mar 18, 2024
Bioforum and Dren Bio (“Dren”) joined forces to focus on Dren’s first clinical trial evaluating DR-01 in patients...